FMR1 and metastatic melanoma: Moreover, a meta-analysis of The Cancer Genome Atlas (TCGA) melanoma data set revealed that increased FMR1 expression level significantly correlates with metastatic melanoma, risk of tumor relapse and reduced disease-free survival.